Sorted By:

Relevance


Statement on Introduction of the Innovation Act, H.R. 9

PhRMA  |  Press Release

Washington, D.C. (February 5, 2015) — The following statement is provided by Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO, John J. Castellani: “We thank Chairman Goodlatte for his leadership in the effort to curb abusive practices that can...
https://www.phrma.org/press-release/statement-on-introduction-of-the-innovation-act-h-r-9

Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/partnership-for-prescription-assistance-relaunches-website-with-new-features-for-patients-and-caregivers

New Report Shows Record Number of Medicines Currently in Development to Treat Diabetes

PhRMA  |  Press Release

The report was released at a press conference featuring American TV icon Jerry Mathers, most famed for his role as “The Beaver” in the television classic, “Leave It To Beaver.”
https://www.phrma.org/press-release/new-report-shows-record-number-of-medicines-currently-in-development-to-treat-diabetes

PhRMA Names Ieva M. Augstums as Deputy Vice President, Communications and Public Affairs

PhRMA  |  Press Release

Before that, she spent 10 years as a journalist, writing for the Dallas Morning News, and as a financial writer for the Associated Press.
https://www.phrma.org/press-release/phrma-names-ieva-m-augstums-as-deputy-vice-president-communications-and-public-affairs

PhRMA Reports 836 Medicines and Vaccines in Development to Treat Cancer

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org  www.FromHopetoCures.org  www.Facebook.com/PhRMA  www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-reports-836-medicines-and-vaccines-in-development-to-treat-cancer

Innovative Oncology Medicines Have Led to Impressive Gains in Patient Survivorship

PhRMA  |  Press Release

Castellani released the following statement highlighting the value of innovative cancer medicines for patients, the economy and the U.S. health care system: “As leaders in the oncology community convene at the 2013 Association of Clinical Oncology meeting to share the latest developments in cancer research, it is important to put into context the invaluable contributions that biopharmaceutical companies have made in the fight against these terrible diseases. 
https://www.phrma.org/press-release/innovative-oncology-medicines-have-led-to-impressive-gains-in-patient-survivorship

PhRMA Statement on the President’s FY 2010 Budget Proposal

PhRMA  |  Press Release

(February 26, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement regarding President Obama’s fiscal year 2010 budget: “PhRMA congratulates the President on a budget proposal that lays a solid foundation for essential comprehensive healthcare reform.
https://www.phrma.org/press-release/phrma-statement-on-the-president-s-fy-2010-budget-proposal

Joint Industry Statement: Internet Sales and Access to Safe Medicines

PhRMA  |  Press Release

Customs and Border Protection, Newsroom, 2012 European Commission, Headlines, 2011 Interpol, News and Media, 2011 PSI, 2012 PSI, News and Media, 2012
https://www.phrma.org/press-release/joint-industry-statement-internet-sales-and-access-to-safe-medicines

Nearly 400 Medicines and Vaccines In Development to Fight Infectious Diseases

PhRMA  |  Press Release

Boston, Mass. (Sept. 10, 2010) — Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America’s biopharmaceutical research companies this ...
https://www.phrma.org/press-release/nearly-400-medicines-and-vaccines-in-development-to-fight-infectious-diseases

PhRMA Statement on Senate HELP Committee Hearing on Securing the Pharmaceutical Supply Chain

PhRMA  |  Press Release

Washington, D.C. (September 14, 2011) – Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President Karl Uhlendorf issued the following statement:   “Biopharmaceutical research companies are committed to ensuring America’s patients receive safe and r...
https://www.phrma.org/press-release/phrma-statement-on-senate-help-committee-hearing-on-securing-the-pharmaceutical-supply-chain

Nearly 90 Medicines and Vaccines In Development for HIV/AIDS

PhRMA  |  Press Release

Washington, D.C. (December 1, 2011) — America’s biopharmaceutical research companies are testing 88 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA).  While...
https://www.phrma.org/press-release/nearly-90-medicines-and-vaccines-in-development-for-hiv/aids

Partnership for Prescription Assistance Ready to Help Storm Victims Across the South

PhRMA  |  Press Release

Washington, D.C. (May 3, 2011) —The Partnership for Prescription Assistance (PPA) is helping uninsured and financially struggling storm victims across the South. A disaster relief form is now available for patients who have been affected by the recent tornadoes and flooding to he...
https://www.phrma.org/press-release/partnership-for-prescription-assistance-ready-to-help-storm-victims-across-the-south

PhRMA Urges Trans-Pacific Partnership Negotiators to Adopt a Strong Intellectual Property Framework

PhRMA  |  Press Release

SINGAPORE (March 4, 2013) –The Pharmaceutical Research and Manufacturers of America (PhRMA) today called on nations participating in the 16th round of Trans-Pacific Partnership (TPP) negotiations to prioritize the protection of intellectual property, citing the critica...
https://www.phrma.org/press-release/phrma-urges-trans-pacific-partnership-negotiators-to-adopt-a-strong-intellectual-property-framework

PhRMA, Families USA Jointly Promote Measures To Ensure Quality, Affordable Healthcare Coverage

PhRMA  |  Press Release

Washington, D.C. (April 21, 2009) – The Pharmaceutical Research and Manufacturers of America (PhRMA) and the national consumer health organization Families USA today unveiled a campaign to promote three key policies designed to help achieve high-quality, affordable health coverag...
https://www.phrma.org/press-release/phrma-families-usa-jointly-promote-measures-to-ensure-quality-affordable-healthcare-coverage

Christopher Viehbacher Continues as PhRMA Board Chair; John Lechleiter, Robert Hugin Assume New Posts

PhRMA  |  Press Release

Washington, D.C. (April 15, 2011) — Christopher Viehbacher, Chief Executive Officer of sanofi-aventis, resumed his role as board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association’s annual meeting in Jersey City, New Jersey...
https://www.phrma.org/press-release/christopher-viehbacher-continues-as-phrma-board-chair-john-lechleiter-robert-hugin-assume-new-posts

Rod Hunter Joins PhRMA as Senior VP, International Advocacy

PhRMA  |  Press Release

Washington, D.C. (May 9, 2011) — The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Rod Hunter has been named Senior Vice President of International Advocacy, effective June 10, 2011. Hunter will report to Executive Vice President of Advocacy Ch...
https://www.phrma.org/press-release/rod-hunter-joins-phrma-as-senior-vp-international-advocacy

PhRMA Applauds Nomination of Kathleen Sebelius as HHS Secretary

PhRMA  |  Press Release

Washington, D.C. (March 2, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today on Kathleen Sebelius’ selection as incoming Department of Health and Human Services Secretary: “Kansas Gov. K...
https://www.phrma.org/press-release/phrma-applauds-nomination-of-kathleen-sebelius-as-hhs-secretary

PhRMA Commends SCHIP Passage In Letter to House Speaker Nancy Pelosi

PhRMA  |  Press Release

Washington, D.C. (January 14, 2009) — The track record of success demonstrated by the State Children’s Health Insurance Program (SCHIP) would be continued – and expanded – by passage of the Children’s Health Insurance Program Reauthorization Act of 2009, said Billy Tauzin, presid...
https://www.phrma.org/press-release/phrma-commends-schip-passage-in-letter-to-house-speaker-nancy-pelosi

Rx Response Director Erin Mullen Receives Outstanding Achievement Award

PhRMA  |  Press Release

New Orleans, LA (March 27, 2013) – Rx Response Director and PhRMA Associate Vice President for IT & Operations Erin Mullen, PhD., RPh, CEM, received the Outstanding Achievement Award for Preparedness at the National Hurricane Conference in New Orleans today. Mullen was...
https://www.phrma.org/press-release/rx-response-director-erin-mullen-receives-outstanding-achievement-award

AstraZeneca’s Chip Davis Joins PhRMA To Assist Organization in Leadership Transition

PhRMA  |  Press Release

Washington, D.C. (April 7, 2010) — Chip Davis, Vice President of Corporate External Relations, AstraZeneca, is joining the Pharmaceutical Research and Manufacturers of America (PhRMA) as Senior Operating Officer to help with the Association’s leadership transition. Davis will rep...
https://www.phrma.org/press-release/astrazeneca-s-chip-davis-joins-phrma-to-assist-organization-in-leadership-transition

PhRMA Elects Four New Members to Board of Directors

PhRMA  |  Press Release

Ian Read, President and Chief Executive Officer, PfizerJerzy Gruhn, President, Novo Nordisk Inc.Mark Iwicki, President and Chief Operating Officer, Sunovion Pharmaceuticals Inc.Staffan Schüberg, President, Lundbeck Inc. Washington, D.C. (December 21, 2010...
https://www.phrma.org/press-release/phrma-elects-four-new-members-to-board-of-directors

Pilot Programs to Focus on Alzheimer’s Disease, Autoimmune Disorders and Type 2 Diabetes

PhRMA  |  Press Release

Washington, D.C. (February 4, 2014) – The Pharmaceutical Research and Manufacturers of America (PhRMA) has joined the National Institutes of Health (NIH),  10 biopharmaceutical companies and several non-profit disease foundations in a partnership to transform the current model fo...
https://www.phrma.org/press-release/pilot-programs-to-focus-on-alzheimer-s-disease-autoimmune-disorders-and-type-2-diabetes

PhRMA Statement on India Supreme Court Decision on Glivec

PhRMA  |  Press Release

WASHINGTON, D.C. (April 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today: “PhRMA is very disappointed with the Indian Supreme Court’s decision to deny a patent on Glivec. This dec...
https://www.phrma.org/press-release/phrma-statement-on-india-supreme-court-decision-on-glivec

James C. Stansel is new Executive V.P. & General Counsel

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/james-c-stansel-joins-phrma-as-executive-vice-president-and-general-counsel

Rotary International and PhRMA team up for “The World’s Biggest Commercial”

PhRMA  |  Press Release

To download images and video please visit Rotary’s Media Center.
https://www.phrma.org/press-release/rotary-international-and-phrma-team-up-for-the-world-s-biggest-commercial

You have reviewed the first 375 results out of 880. Each page contains 25 results. You're on page 15.

prev 13 14 15 16 17 18 next